Video
Author(s):
As new treatments are developed for multiple sclerosis one of the questions has become how do you measure their success. A possible metric being developed is No Evidence of Disease Activity or NEDA.
As new treatments are developed for multiple sclerosis one of the questions has become how do you measure their success. A possible metric being developed is No Evidence of Disease Activity or NEDA.
Speaking at the annual meeting of the Consortium of Multiple Sclerosis Centers Clyde Markowitz, MD, from the University of Pennsylvania said that not only are there questions about what NEDA means but also which model of it provides the best and most definitive results to help guide a patient's care.